Driven by a common objective to improve Tianjin’s foreign investment climate and advance healthcare services in the city, AmCham China’s Healthcare Industry Group, in collaboration with the Tianjin Investment Promotion Bureau, organized a delegation visit on March 19, 2024. The delegation comprised representatives from 26 multinational healthcare companies, including Boston Scientific, Stryker, Edwards Lifesciences, Amgen, Johnson & Johnson, Alcon, AbbVie, Abbott, Medtronic, and others, for business inspections and policy discussions.
基于共同支持天津市优化外商投资环境和提高天津市医疗服务质量的共同出发点，在天津市投资促进局的支持下，中国美国商会医疗组带领来自二十六家在华跨国医疗企业的代表于2024年3月19日赴天津进行商务考察和开展政企交流，包括波士顿科学、史赛克、爱德华、安进、强生、爱尔康、艾伯维、雅培、美敦力等。
Exploratory Visit and Exchange at Tianjin Port Free Trade Zone
Edward Wang, Director of the AmCham China Healthcare Industry Group, along with representatives from various companies, visited the Tianjin Port Free Trade Zone (Tianjin Port FTZ) to gain insights into its founding history, the development of the healthcare industry, and supportive policies. During a meeting between the AmCham China Healthcare Working Group and the FTZ, leaders from the FTZ’s Bureau of Commerce, Investment Promotion Bureau, Social Development Bureau, and Free Trade Work Bureau provided detailed explanations of the medical policies within the FTZ. These included specifics about implementing policies that support the clinical use of urgently needed medications approved by the National Medical Products Administration but not yet available in mainland China. These policies facilitate clinical applications in Level III hospitals within the Tianjin Free Trade Zone, alongside medical cooperation under the coordinated development of Beijing, Tianjin, and Hebei. Company representatives expressed their appreciation for the insights gained during the business inspection and showed willingness to explore cooperation opportunities with the Tianjin Port FTZ.
中国美国商会医疗组总监王曦携一众企业代参观了天津港保税区(Tianjin Port Free Trade Zone)，深入了解保税区的成立历史、医疗行业发展情况以及支持性政策。在中国美国商会医疗工作组与天津保税区的交流会上，天津港保税区管委会招商局、投促局、社发局以及自贸工作局的领导向企业代表详细解读了保税区内医疗相关政策的执行细则，比如关于“支持已经国家药监局批准的境外已上市、境内未上市临床急需用药在天津自贸试验区三级医院依法开展临床应用，同步开展京津冀协同发展下的医疗合作。”政策的实践情况。企业代表纷纷表示此次商务考察受益良多，将会愿意共同探索与天津港保税区的合作机会。
Healthcare Policy Roundtable Meeting and “One-on-One” Closed-Door Meetings:
The Healthcare Industry Group and the Tianjin Investment Promotion Bureau jointly organized a Healthcare Policy Roundtable Meeting. The Tianjin Healthcare Security Administration and the Tianjin Health Commission were invited to attend. Government and enterprise representatives engaged in professional and productive discussions on topics such as volume-based procurement, universal medical insurance, drug supply security, and the “Dual-Channel” policy.
Recognizing the diverse issues faced by companies in policy matters, the Tianjin Investment Promotion Bureau introduced a “one-on-one” business dialogue mechanism for the first time after the roundtable meeting. Nine companies participated in closed-door meetings, communicating separately with the Tianjin Investment Promotion Bureau and related government departments. These meetings demonstrated the proactive service orientation of the Tianjin municipal government, its pragmatic and efficient problem-solving attitude, and its determination to provide comprehensive service guarantees for enterprises. Meanwhile, AmCham China and its member companies pledged unwavering support for the Tianjin municipal government’s efforts to optimize the foreign investment environment and attract foreign investment.
中国美国商会医疗工作组与天津市投资促进局共同举办了天津市医疗政策交流座谈会，天津市医疗保障局和天津市卫生健康委员会受邀出席会议。政企就带量采购、全民医保、药品供应保障、双通道政策等议题进行了专业而富有成效的互动。
考虑到企业产品和企业在政策所遇到问题的差异性，天津市投资促进局联合商会在座谈交流会后首次开设“一对一”企业对话机制。九家企业参与闭门交流会，与天津市投资促进局和相关政府部门之间分别进行沟通。两场会议展现了天津市政府积极的服务意识，务实高效解决问题的态度以及为企业提供全方位服务保障的决心。与此同时，商会及其会员企业也会更加坚定不移地支持天津市政府优化外商投资环境、加大吸引外商投资的工作。
